$2.94
6.37% yesterday
Nasdaq, Nov 03, 10:11 pm CET

Maravai LifeSciences Stock price

$2.94
-0.15 4.85% 1M
+0.82 38.68% 6M
-2.51 46.06% YTD
-4.83 62.16% 1Y
-11.57 79.74% 3Y
-26.91 90.15% 5Y
-26.91 90.15% 10Y
-26.91 90.15% 20Y
Nasdaq, Closing price Mon, Nov 03 2025
-0.20 6.37%

Key metrics

Basic
Market capitalization
$801.8m
Enterprise Value
$857.3m
Net debt
$55.5m
Cash
$269.9m
Shares outstanding
255.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3.7 | 4.1
EV/Sales
4.0 | 4.4
EV/FCF
negative
P/B
3.0
Financial Health
Equity Ratio
32.3%
Return on Equity
-44.5%
ROCE
-13.7%
ROIC
-18.6%
Debt/Equity
1.2
Financials (TTM | estimate)
Revenue
$215.9m | $195.9m
EBITDA
$-112.5m | $-31.2m
EBIT
$-113.6m | $-79.3m
Net Income
$-194.7m | $-81.9m
Free Cash Flow
$-45.2m
Growth (TTM | estimate)
Revenue
-22.5% | -24.4%
EBITDA
-70,381.3% | 54.2%
EBIT
-148.8% | -12.2%
Net Income
-47.4% | 43.5%
Free Cash Flow
-166.3%
Margin (TTM | estimate)
Gross
29.1%
EBITDA
-52.1% | -15.9%
EBIT
-52.7%
Net
-90.2% | -41.8%
Free Cash Flow
-20.9%
More
EPS
$-1.4
FCF per Share
$-0.2
Short interest
11.0%
Employees
580
Rev per Employee
$450.0k
Show more

Is Maravai LifeSciences a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.

Maravai LifeSciences Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Maravai LifeSciences forecast:

10x Buy
59%
7x Hold
41%

Analyst Opinions

17 Analysts have issued a Maravai LifeSciences forecast:

Buy
59%
Hold
41%

Financial data from Maravai LifeSciences

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
216 216
23% 23%
100%
- Direct Costs 153 153
3% 3%
71%
63 63
52% 52%
29%
- Selling and Administrative Expenses 157 157
1% 1%
73%
- Research and Development Expense 19 19
0% 0%
9%
-112 -112
70,381% 70,381%
-52%
- Depreciation and Amortization 1.20 1.20
97% 97%
1%
EBIT (Operating Income) EBIT -114 -114
149% 149%
-53%
Net Profit -195 -195
47% 47%
-90%

In millions USD.

Don't miss a Thing! We will send you all news about Maravai LifeSciences directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Maravai LifeSciences Stock News

Neutral
GlobeNewsWire
6 days ago
Allegedly, Maravai misstated revenue and overstated goodwill due to weak internal controls, causing a 22% stock drop after delaying its earnings report.
Neutral
Business Wire
12 days ago
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its third quarter 2025 financial and operating results after the market close on Thursday, November 6, 2025, and will host a conference call and webcast on the same day at 2:00 p.m. PT/ 5:00 p.m. ET. To ...
Neutral
GlobeNewsWire
about one month ago
Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Maravai (MRVI) To Contact Him Directly To Discuss Their Options If you purchased or acquired common stock in Maravai LifeSciences between August 7, 2024 and February 24, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner  Brandon Walker or Marion Passmor...
More Maravai LifeSciences News

Company Profile

Maravai Lifesciences Holdings, Inc. operates as an investment holding company. It develops biopharmaceuticals. The company is headquartered in San Diego, CA.

Head office United States
CEO William Martin
Employees 580
Founded 2014
Website www.maravai.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today